Dr. Anna Parks and Dr. Kenneth Covinsky of the University of California, San Francisco, say, “Balancing the tradeoffs required for anticoagulation will remain challenging in patients with limited life expectancy. Our goal should be a framework that combines quantitative information with patients’ values to guide clinicians and patients toward individualized and informed decisions.”
The study had no commercial funding. The authors have no relevant disclosures. Dr. Covinsky is associate editor of JAMA Internal Medicine.
Pages: 1 2 | Single Page
No Responses to “Anticoagulation Common Near End of Life in Dementia Patients with Atrial Fibrillation”